Core Viewpoint - Chongqing Zaiseng Technology Co., Ltd. has announced the use of part of its temporarily idle self-owned funds for cash management by purchasing low-risk financial products, with a maximum investment of RMB 400 million and a management period not exceeding 12 months [2][4]. Group 1: Basic Situation - The company held a board meeting on October 8, 2024, where it approved the proposal to use up to RMB 400 million of temporarily idle self-owned funds for cash management, ensuring that it does not affect the normal development of its main business [2]. - The company purchased RMB 110 million worth of financial products from China Merchants Bank on July 31, 2025, which has now matured and been redeemed [3][4]. Group 2: Risk Control Measures - The company will analyze and monitor the financial products regularly, reporting any adverse factors to the board and taking necessary protective measures [4]. - A cash management product management system has been established to regulate daily management, risk control, and information disclosure [4]. - The audit department is responsible for auditing the use and custody of financial products, with quarterly checks on structured deposit products [4].

证券代码：600713 证券简称：南京医药 编号：ls2025-114 使用部分暂时闲置募集资金进行现金管理到期赎回并继续 进行现金管理的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ? 现金管理受托方：招商银行股份有限公司（以下简称"招商银行"） ? 本次现金管理金额：9,000万元（人民币，下同） ? 现金管理产品名称：南京医药股份有限公司（以下简称"公司"）子公 司福建同春药业股份有限公司（以下简称"福建同春"）本次使用部分暂时闲置 募集资金 9,000 万元购买招商银行点金系列看涨两层区间 91 天结构性存款。 ? 履行的审议程序：公司于2025年1月20-22日召开了第九届董事会临时会 议及第九届监事会临时会议，审议通过了《关于公司及子公司使用部分暂时闲置 募集资金进行现金管理的议案》，同意公司及子公司使用不超过7亿元（含本数） 暂时闲置募集资金进行现金管理，投资的产品品种为安全性较高、流动性较好、 风险较低的保本型理财产品。使用期限自公司董事会审议通过之日起12个月内有 效，上述额度在使用期 ...

Fundraising Overview - The company raised a total of RMB 1,840,000,000.00 from the issuance of 20,000,000 shares at a price of RMB 92.00 per share, with net proceeds after fees amounting to RMB 1,671,699,800.72 [1][2] - The funds were verified by Lixin Certified Public Accountants [2] Fund Usage and Management - As of June 30, 2025, the company has established a dedicated account for the management of the raised funds, ensuring compliance with relevant regulations [4][5] - The company has not used idle funds for temporary working capital during the reporting period [6][9] - The company has approved the use of up to RMB 12 billion of temporarily idle funds for cash management, ensuring that it does not affect project construction or fund safety [7][8] Changes in Fund Allocation - The company has adjusted the internal investment structure and implementation content of its fundraising projects, specifically for the "Vehicle Ethernet Chip Development and Industrialization Project" and the "Research and Development Center Construction Project" [12][13] - The company has utilized RMB 12,213.35 million of self-raised funds for project expenses, which will be replaced by the raised funds later [11] Compliance and Reporting - The company has confirmed that there are no issues with the disclosure of fundraising information, and all management practices comply with regulations [13][21] - The supervisory board has approved the half-year report and the special report on the storage and actual use of raised funds, affirming that the information is accurate and complete [20][22] Upcoming Investor Interaction - The company will participate in a collective performance briefing for the chip design industry on September 8, 2025, to address investor inquiries regarding its half-year performance [24][25]

Core Points - The company Shanghai Hejing Silicon Materials Co., Ltd. has reported on the status of its fundraising activities for the first half of 2025, confirming compliance with relevant regulations and the proper management of raised funds [1][12]. Fundraising Overview - The company issued 66,206,036 shares at a price of 22.66 RMB per share, raising a total of approximately 1.5 billion RMB, with a net amount of about 1.39 billion RMB after deducting issuance costs [1]. - As of June 30, 2025, the company has utilized approximately 868.68 million RMB of the raised funds, leaving a balance of about 537.75 million RMB [2]. Fund Management - The company has established a fundraising management system to ensure the safety and proper use of the raised funds, in accordance with the Shanghai Stock Exchange regulations [2]. - A tripartite supervision agreement has been signed with banks to oversee the management of the fundraising account, ensuring compliance with legal requirements [3]. Cash Management - The company has approved the use of up to 735 million RMB of temporarily idle funds for cash management, focusing on low-risk, high-liquidity financial products [5]. - As of June 30, 2025, the balance of idle funds under cash management was approximately 482.55 million RMB [6]. Fund Usage and Adjustments - There were no instances of using idle funds to temporarily supplement working capital during the reporting period [6]. - The company has not made any changes to the fundraising projects or reported any surplus funds as of June 30, 2025 [11][7]. Project Delays - The timeline for the "High-Quality Epitaxial Wafer R&D and Industrialization Project" has been extended to December 2026 due to market demand changes [10].

Group 1 - The company plans to hold the second extraordinary general meeting of shareholders on September 16, 2025, with both on-site and online voting options available [5][6][7] - The meeting will take place at the company's conference room located at 15 Linbu Street, Suzhou Industrial Park, starting at 14:30 [5][11] - Shareholders must register to attend the meeting, with registration available from September 11, 2025 [14][16] Group 2 - The company has proposed amendments to its articles of association, which will be submitted for approval at the upcoming shareholders' meeting [2][30] - The board of supervisors has approved the company's half-year report and the special report on the use of raised funds, with all resolutions passed unanimously [23][26] - The company has added new implementation entities and locations for its fundraising projects, which will not affect the original purpose of the funds [33][35] Group 3 - The company intends to use up to RMB 400 million of idle self-owned funds for cash management, aiming to improve the efficiency and returns of its capital [42][43] - The investment will be in low-risk financial products, ensuring that daily operations and capital turnover are not affected [51][52] - The board has approved this cash management plan without needing to submit it to the shareholders' meeting [47]

Group 1 - The core viewpoint of the report is to provide a comprehensive overview of the company's financial performance, operational status, and future development plans for the first half of 2025 [1] - The company has issued 70 million shares at a price of 15.32 RMB per share, raising a total of 1,072.40 million RMB, with a net amount of 970.05 million RMB after deducting issuance costs [2][5] - The company has established a special account for the management of raised funds, ensuring that all funds are stored in accordance with regulatory requirements [3][4] Group 2 - As of June 30, 2025, the company has utilized 48.92 million RMB of the raised funds for investment projects [5] - The company has approved the use of raised funds to replace 92.38 million RMB of self-raised funds that were previously invested in projects [5][6] - There are no instances of using idle raised funds to temporarily supplement working capital as of June 30, 2025 [6] Group 3 - The company has approved the use of up to 520 million RMB of temporarily idle raised funds for cash management, with an outstanding balance of 228 million RMB as of June 30, 2025 [7] - There are no cases of using over-raised funds to permanently supplement working capital or repay bank loans [8] - The company has invested 39.36 million RMB of over-raised funds into a new production project for its wholly-owned subsidiary [9] Group 4 - As of June 30, 2025, there are no surplus raised funds remaining [10] - The company has postponed the expected operational date for a project from December 2024 to December 2026, adjusting the funding allocation for other projects accordingly [11][12] - The company has reported no significant issues in the use and disclosure of raised funds during the first half of 2025 [15]

Core Points - The company does not plan to distribute profits or increase capital from reserves for the first half of 2025 [3] - The board of directors and supervisory board confirm the accuracy and completeness of the half-year report [1][5] - The half-year report has not been audited [2] Company Overview - The company is Zhejiang Wanfeng Chemical Co., Ltd. with stock code 603172 [5] - The report includes major operational data for the first half of 2025, but specific figures for production, sales, and revenue are not disclosed in the provided text [5] Important Matters - There were no significant changes in the company's operational situation during the reporting period [4][6] - No other matters that significantly impact the company's operations were reported during the period [6] Fundraising and Usage - The company raised a total of RMB 486.68 million from its initial public offering, with a net amount of RMB 420.59 million after deducting issuance costs [15] - As of June 30, 2025, the company had idle fundraising cash management balances of approximately RMB 234.27 million [17] - The company has established a fundraising management system to ensure compliance with relevant regulations [18] Fund Management Agreements - The company has signed tripartite supervision agreements with its underwriters and banks to manage the fundraising [19] - The company has not used idle funds to temporarily supplement working capital during the reporting period [23] Project Updates - The company has postponed certain fundraising investment projects due to delays in equipment delivery and macroeconomic factors [30] - The "Annual Production of 10,000 Tons of Disperse Dye Technological Upgrade Project" is now expected to be completed by December 2025, and the "Research and Development Center Construction Project" is postponed to December 2026 [30] Compliance and Reporting - The company has complied with all relevant laws and regulations regarding the use of fundraising and has disclosed the usage status appropriately [32] - There were no violations in the usage and disclosure of fundraising during the reporting period [32]

Meeting Overview - The second meeting of the second board of directors of Yangzhou Tianfulong Group Co., Ltd. was held on August 29, 2025, with all 9 directors present [1] - The meeting was chaired by Chairman Zhu Daqing, with attendance from all supervisors and relevant senior management [1] Resolutions Passed - The board approved the proposal to use raised funds to replace pre-invested project funds and paid issuance expenses, with a unanimous vote of 9 in favor [2] - The board approved the proposal to use part of the idle raised funds and self-owned funds for cash management, also with a unanimous vote of 9 in favor [2] - The board approved the proposal to use self-owned funds and bank acceptance bills to pay part of the project funds and replace them with raised funds, again with a unanimous vote of 9 in favor [2] - The board approved the proposal to change the company's registered capital, company type, cancel the supervisory board, and amend the Articles of Association, with a unanimous vote of 9 in favor [3] - The board approved the proposal to revise and add certain internal governance systems, which will require submission to the shareholders' meeting for approval [3][4] - The board approved the proposal to convene the first temporary shareholders' meeting of 2025, with a unanimous vote of 9 in favor [3]

Meeting Overview - The second session of the second Supervisory Board of Yangzhou Tianfulong Group Co., Ltd. was held on August 29, 2025, in compliance with relevant laws and regulations [1] - The meeting was attended by all three supervisors, with one participating via communication [1] Resolutions Passed - The Supervisory Board approved the proposal to use raised funds to replace self-raised funds that were previously invested in fundraising projects and to cover issuance costs. This replacement occurred within six months of the raised funds being received, complying with regulatory requirements [1] - The Supervisory Board also approved the use of part of the idle raised funds and self-owned funds for cash management, emphasizing that this would not affect the implementation of investment projects [2] - Additionally, the Supervisory Board agreed to use self-owned funds and bank acceptance bills to pay for part of the fundraising project costs, with an equivalent amount to be replaced by raised funds. This decision was made to optimize payment methods and improve fund utilization efficiency [3]

Core Viewpoint - The company plans to utilize part of its idle raised funds and self-owned funds for cash management, focusing on high-safety, liquid, and principal-protected financial products, ensuring that this does not affect the normal operation and investment projects of the company [1][4][6]. Fundraising Overview - The company has successfully raised a total of RMB 944.24 million through the issuance of 40.01 million shares at RMB 23.60 per share, with a net amount of RMB 855.91 million after deducting issuance costs [2][3]. - The excess raised funds amount to RMB 65.91 million, and all raised funds have been verified and accounted for [2][3]. Investment Project Details - The net proceeds from the fundraising will be allocated to projects related to the main business, including a production project for low-melting-point polyester fibers and a research center for recycled short fibers, with a total investment of RMB 114.53 million [3]. Cash Management Plan - The company intends to invest up to RMB 2.60 billion of idle raised funds and up to RMB 14.00 billion of idle self-owned funds in safe, liquid, principal-protected financial products, with individual product terms not exceeding 12 months [1][4][5]. - The cash management plan is designed to enhance fund utilization efficiency and generate additional income for the company and its shareholders [4][6]. Approval Process - The cash management proposal was approved in the board and supervisory meetings held on August 29, 2025, and does not require further shareholder approval [2][7]. Monitoring and Compliance - The company has established a special account for the management of raised funds and signed a tripartite supervision agreement with the bank and sponsor to ensure compliance and protect investor interests [3][5]. - The company will disclose the cash management activities in accordance with relevant regulations and guidelines [5][7].